Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the transaction, the director directly owned 2,648 shares of the company’s stock, valued at $995,806.88. This represents a 77.25% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Astera Labs Trading Down 1.4%
NASDAQ ALAB traded down $4.84 during trading hours on Friday, hitting $342.21. 4,063,848 shares of the company’s stock were exchanged, compared to its average volume of 5,191,571. The firm has a market cap of $59.37 billion, a price-to-earnings ratio of 169.41 and a beta of 3.68. The stock has a 50-day simple moving average of $316.82 and a 200 day simple moving average of $290.03. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48.
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Astera Labs
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Astera Labs introduced Aries 7, described as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The lineup includes retimers, redrivers, cable modules, optical drivers and optical transimpedance amplifiers, positioning the company to benefit from expanding AI infrastructure and higher-speed data-center connectivity. Astera Labs Announces Aries 7
- Positive Sentiment: Marvell’s projection that connecting AI chips could become a $37 billion business reinforced investor optimism about the broader AI-connectivity market and helped highlight Astera’s growth opportunity. However, the companies discussed in the coverage remain dependent on major customers. Marvell AI Connectivity Market Forecast
- Neutral Sentiment: Analysts and market coverage are comparing Astera’s role in connecting AI racks with Micron’s memory and system exposure. Astera offers substantial growth potential, but competition from Marvell and Credo is intensifying. Micron Versus Astera Labs
- Negative Sentiment: Northland Securities downgraded ALAB from “outperform” to “market perform,” adding pressure to the shares and signaling that the current valuation may already reflect substantial AI-related growth. Northland Securities Downgrade
- Negative Sentiment: Jim Cramer praised Astera’s business but criticized its price, reinforcing concerns that the stock’s valuation leaves limited room for execution mistakes or slower growth. Jim Cramer Discusses Astera Labs Valuation
Analyst Upgrades and Downgrades
Several research firms have weighed in on ALAB. Roth Capital reaffirmed a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Stifel Nicolaus raised their target price on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Susquehanna boosted their target price on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Friday. Finally, Needham & Company LLC increased their price target on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $348.33.
Get Our Latest Stock Analysis on ALAB
About Astera Labs
Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.
The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.
Featured Stories
- Five stocks we like better than Astera Labs
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
